- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-1-1-3-3-mer
- Ligands
- 3 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 1 x NAG- NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 55 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
NAG.6: 3 residues within 4Å:- Chain C: N.135, S.185, Q.186
Ligand excluded by PLIPNAG.7: 3 residues within 4Å:- Chain C: T.140, N.152, G.315
Ligand excluded by PLIPNAG.8: 3 residues within 4Å:- Chain C: S.154, F.155, N.156
Ligand excluded by PLIPNAG.9: 4 residues within 4Å:- Chain C: V.178, Q.179, R.188, N.193
Ligand excluded by PLIPNAG.10: 3 residues within 4Å:- Chain C: N.226, T.228
- Ligands: NAG.11
Ligand excluded by PLIPNAG.11: 3 residues within 4Å:- Chain C: N.225, N.237
- Ligands: NAG.10
Ligand excluded by PLIPNAG.12: 3 residues within 4Å:- Chain C: E.265, N.285, E.286
Ligand excluded by PLIPNAG.13: 4 residues within 4Å:- Chain C: N.297, G.434, N.435
- Ligands: NAG.16
Ligand excluded by PLIPNAG.14: 5 residues within 4Å:- Chain C: R.322, Y.325, N.327, S.406, T.408
Ligand excluded by PLIPNAG.15: 5 residues within 4Å:- Chain C: T.366, T.367, N.380, S.382, R.412
Ligand excluded by PLIPNAG.16: 4 residues within 4Å:- Chain C: N.435, I.436, T.437
- Ligands: NAG.13
Ligand excluded by PLIPNAG.17: 5 residues within 4Å:- Chain C: S.287, V.288, K.289, S.440, N.441
Ligand excluded by PLIPNAG.18: 3 residues within 4Å:- Chain C: T.137, N.138, I.146
Ligand excluded by PLIPNAG.19: 3 residues within 4Å:- Chain C: E.92, N.93
- Chain D: T.18
Ligand excluded by PLIPNAG.20: 3 residues within 4Å:- Chain C: N.334, E.335, W.389
Ligand excluded by PLIPNAG.21: 3 residues within 4Å:- Chain D: Q.141, Q.142, N.145
Ligand excluded by PLIPNAG.22: 4 residues within 4Å:- Chain D: N.100, S.101, T.102, W.103
Ligand excluded by PLIPNAG.23: 3 residues within 4Å:- Chain E: N.135, S.185, Q.186
Ligand excluded by PLIPNAG.24: 5 residues within 4Å:- Chain E: T.140, N.152, N.169, A.170, L.171
Ligand excluded by PLIPNAG.25: 4 residues within 4Å:- Chain E: S.154, F.155, N.156, K.167
Ligand excluded by PLIPNAG.26: 3 residues within 4Å:- Chain E: V.178, R.188, N.193
Ligand excluded by PLIPNAG.27: 4 residues within 4Å:- Chain E: N.226, T.228, N.236
- Ligands: NAG-NAG.2
Ligand excluded by PLIPNAG.28: 4 residues within 4Å:- Chain E: G.264, E.265, N.285, E.286
Ligand excluded by PLIPNAG.29: 3 residues within 4Å:- Chain E: N.297, I.318
- Ligands: NAG.32
Ligand excluded by PLIPNAG.30: 5 residues within 4Å:- Chain E: Y.325, N.327, S.406, I.407, T.408
Ligand excluded by PLIPNAG.31: 4 residues within 4Å:- Chain E: T.366, T.367, N.380, S.382
Ligand excluded by PLIPNAG.32: 4 residues within 4Å:- Chain E: N.297, N.435, T.437
- Ligands: NAG.29
Ligand excluded by PLIPNAG.33: 4 residues within 4Å:- Chain E: L.261, S.287, N.441
- Ligands: NAG-NAG-BMA.3
Ligand excluded by PLIPNAG.34: 3 residues within 4Å:- Chain E: N.352, T.388, W.389
Ligand excluded by PLIPNAG.35: 2 residues within 4Å:- Chain E: P.357, N.386
Ligand excluded by PLIPNAG.36: 2 residues within 4Å:- Chain E: N.272, T.274
Ligand excluded by PLIPNAG.37: 1 residues within 4Å:- Chain E: N.93
Ligand excluded by PLIPNAG.38: 4 residues within 4Å:- Chain E: T.137, N.138, I.146, K.151
Ligand excluded by PLIPNAG.39: 2 residues within 4Å:- Chain F: N.100, T.102
Ligand excluded by PLIPNAG.40: 4 residues within 4Å:- Chain F: K.122, E.123, S.125, N.126
Ligand excluded by PLIPNAG.41: 1 residues within 4Å:- Chain F: N.105
Ligand excluded by PLIPNAG.42: 3 residues within 4Å:- Chain F: Q.141, Q.142, N.145
Ligand excluded by PLIPNAG.43: 3 residues within 4Å:- Chain G: N.135, S.185, Q.186
Ligand excluded by PLIPNAG.44: 5 residues within 4Å:- Chain G: A.139, T.140, N.152, L.171, Q.316
Ligand excluded by PLIPNAG.45: 3 residues within 4Å:- Chain G: S.154, F.155, N.156
Ligand excluded by PLIPNAG.46: 4 residues within 4Å:- Chain E: R.304
- Chain G: R.188, I.190, N.193
Ligand excluded by PLIPNAG.47: 3 residues within 4Å:- Chain G: N.226, T.228
- Ligands: NAG-NAG-NAG.4
Ligand excluded by PLIPNAG.48: 2 residues within 4Å:- Chain G: N.285, E.286
Ligand excluded by PLIPNAG.49: 3 residues within 4Å:- Chain G: N.297, I.318, G.319
Ligand excluded by PLIPNAG.50: 4 residues within 4Å:- Chain G: Y.325, N.327, S.406, T.408
Ligand excluded by PLIPNAG.51: 2 residues within 4Å:- Chain G: N.435, T.437
Ligand excluded by PLIPNAG.52: 4 residues within 4Å:- Chain G: L.261, S.287, N.441
- Ligands: NAG-NAG-BMA.5
Ligand excluded by PLIPNAG.53: 3 residues within 4Å:- Chain G: E.92, N.93
- Chain H: S.17
Ligand excluded by PLIPNAG.54: 3 residues within 4Å:- Chain G: T.137, N.138, I.146
Ligand excluded by PLIPNAG.55: 1 residues within 4Å:- Chain G: N.386
Ligand excluded by PLIPNAG.56: 3 residues within 4Å:- Chain G: N.380, S.382, P.410
Ligand excluded by PLIPNAG.57: 2 residues within 4Å:- Chain H: S.125, N.126
Ligand excluded by PLIPNAG.58: 3 residues within 4Å:- Chain H: N.100, T.102, Y.127
Ligand excluded by PLIPNAG.59: 3 residues within 4Å:- Chain H: Q.141, Q.142, N.145
Ligand excluded by PLIPNAG.60: 2 residues within 4Å:- Chain H: N.105, K.106
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Pratap, P.P. et al., Immunofocusing on the conserved fusion peptide of HIV envelope glycoprotein in rhesus macaques. Biorxiv (2024)
- Release Date
- 2025-06-25
- Peptides
- RUu-Base-4 pAb heavy chain: A
RUu-Base-4 pAb light chain: B
BG505-CH505 Envelope glycoprotein gp120: CEG
BG505-CH505 Transmembrane protein gp41: DFH - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
HB
LC
CE
AG
ED
DF
BH
F
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-1-1-3-3-mer
- Ligands
- 3 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 1 x NAG- NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 55 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Pratap, P.P. et al., Immunofocusing on the conserved fusion peptide of HIV envelope glycoprotein in rhesus macaques. Biorxiv (2024)
- Release Date
- 2025-06-25
- Peptides
- RUu-Base-4 pAb heavy chain: A
RUu-Base-4 pAb light chain: B
BG505-CH505 Envelope glycoprotein gp120: CEG
BG505-CH505 Transmembrane protein gp41: DFH - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
HB
LC
CE
AG
ED
DF
BH
F